# Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit

> **NCT02285153** · PHASE3 · TERMINATED · sponsor: **Medical University of Vienna** · enrollment: 15 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Acetylsalicylic acid lysinate
- **DRUG:** 0.9% sodium-chloride solution

## Key facts

- **NCT ID:** NCT02285153
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11-15
- **Primary completion:** 2017-09-05
- **Final completion:** 2017-11-10
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Recruitment of planned number of Subjects was not feasible.
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285153, "Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02285153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*